US FDA’s New Acting Generics Chief Relearning System After 24 Years Of Experience

 
• By Derrick Gingery
  
Generic drugs
Susan Rosencrance has been acting OGD director for less than a month. • Source: Shutterstock

More from Generics

More from Biosimilars & Generics